Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > RMTI > Summary

Rockwell Medical Technologies Inc.
(RMTI)

7.27USD   Up0.04 (0.55%)   
At 2:30AM IST
 Rockwell Medical Technologies Inc. (NGM:RMTI) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Last Trade: 7.27USD
Trade Time:2:30AM IST
Change:Up0.04 (0.55%)
Prev Close:7.23
Open:7.50
Bid:6.55 x 300
Ask:8.54 x 600
1y Target Est:11.50
Day's Range:7.23 - 7.31
52wk Range:2.56 - 9.39
Volume:22,314
Avg Vol (3m):56,461.9
Market Cap:124.03M
P/E (ttm):N/A
EPS (ttm):-0.57
Div & Yield:N/A (N/A%)
Add RMTI to Portfolio   Download Data

HEADLINES

 
•ROCKWELL MEDICAL TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers - EDGAR Online  - Thu, Jan 21
•The Best Investing Ideas in Health Care - Motley Fool  - Wed, Dec 16
•Coverage initiated on Rockwell Medical Tech. by JMP Securities - Briefing.com  - Thu, Dec 10
•ROCKWELL MEDICAL TECHNOLOGIES INC Financials - EDGAR Online Financials  - Wed, Nov 11
•ROCKWELL MEDICAL TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statem - EDGAR Online  - Wed, Nov 4
•Rockwell Medical Reports Third Quarter Results; Expanded Gross Profit Margins - GlobeNewswire  - Wed, Nov 4
•Rockwell Medical Presents New Data on Proprietary Iron-Delivery Drug SFP at American Society of Nephrology Annual Meeting - Marketwire  - Mon, Nov 2
•Rockwell Medical Completes SFP Phase IIb Clinical Study - GlobeNewswire  - Thu, Oct 29
•Rockwell Medical Announces New Corporate Name - Marketwire  - Tue, Oct 27
•Rockwell Medical Schedules Investor Conference Call - GlobeNewswire  - Mon, Oct 26
» More Headlines for RMTI...

ANALYST

 
EPS Est (next year) (Dec-09) :-0.42
EPS Est (in 2 years) (Dec-10) :-0.42
Avg Rec (current)*:1.5
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Rockwell Medical Technologies, Inc., an integrated biopharmaceutical company, offers products and services targeting end-stage renal disease, chronic kidney disease, and iron deficiency anemia.

» Full Company Profile